The nucleocapsid (NC) of the rabies virus behaves as an exogenous superantigen (SAg) in humans. In the present report, we analyzed whether it is also a SAg in mice by studying the effect of NC on T cell receptor (TCR) VB expression in BALB/c mice. Repeated injection of NC in newborn BALB/c mice led to a marked reduction by two-to sixfold of V36 expressing CD4 + T cells in spleen and in peripheral blood. Decrease of V36-expressing CD3 + mature T cells was also observed in thymus. Single NC injection in footpad resulted in a three-to sixfold expansion of V36 CD4 + T cells, but not of CD8 + T cells, in the draining lymph nodes of BALB/c mice. The intensity of the stimulation was dose dependent and was maximal 3 d after the NC injection. The donal deletion of T cells bearing a particular V3 demonstrates that NC is a SAg in mice. T cells, especially CD4 + T cells, are an essential factor in host resistance to rabies virus and also in the pathophysiology of paralysis; thus, we postulate that a rabies virus component, which stimulates T cells, such as a SAg, may increase virus immunopathogenicity. To evaluate this hypothesis, we compared the course of rabies in adult BALB/c lacking V36, 7, 8.1, and 9 T cells and in normal BALB/c. Immune-related paralysis was decreased in BALB/c missing the NC target VBT cells. Transfer of V36 but not of V38.1-3 T cells into recipient mice lacking V36, 7, 8.1, and 9 allowed the immune-related paralysis to evolve. Taken together, these results strongly support the hypothesis that T cells expressing rabies SAg-specific V36 T cells, are involved in the genesis of the immunopathology that is characteristic of paralytic rabies.
Stlmmltry
The nucleocapsid (NC) of the rabies virus behaves as an exogenous superantigen (SAg) in humans.
In the present report, we analyzed whether it is also a SAg in mice by studying the effect of NC on T cell receptor (TCR) VB expression in BALB/c mice. Repeated injection of NC in newborn BALB/c mice led to a marked reduction by two-to sixfold of V36 expressing CD4 + T cells in spleen and in peripheral blood. Decrease of V36-expressing CD3 + mature T cells was also observed in thymus. Single NC injection in footpad resulted in a three-to sixfold expansion of V36 CD4 + T cells, but not of CD8 + T cells, in the draining lymph nodes of BALB/c mice. The intensity of the stimulation was dose dependent and was maximal 3 d after the NC injection. The donal deletion of T cells bearing a particular V3 demonstrates that NC is a SAg in mice. T cells, especially CD4 + T cells, are an essential factor in host resistance to rabies virus and also in the pathophysiology of paralysis; thus, we postulate that a rabies virus component, which stimulates T cells, such as a SAg, may increase virus immunopathogenicity. To evaluate this hypothesis, we compared the course of rabies in adult BALB/c lacking V36, 7, 8.1, and 9 T cells and in normal BALB/c. Immune-related paralysis was decreased in BALB/c missing the NC target VBT cells. Transfer of V36 but not of V38.1-3 T cells into recipient mice lacking V36, 7, 8.1, and 9 allowed the immune-related paralysis to evolve. Taken together, these results strongly support the hypothesis that T cells expressing rabies SAg-specific V36 T cells, are involved in the genesis of the immunopathology that is characteristic of paralytic rabies. S uperantigens (SAgs) 1 are defined by the capacity to stimulate a large fraction of T cells predominantly on the basis of the Vl3 elements of the TCR (1) . Unlike conventional antigens, they do not require antigen processing and bind outside the peptide binding groove by clamping the MHC class II and the TCR molecules (2, 3) . The best studied SAgs are the bacterial enterotoxins produced by Staphylococcus aureus, the most potent T cell activators known so far (4) . SAgs are also produced by other bacteria, mycoplasma (4, 5) , and have been found to be encoded by exogenous and endogenous mouse mammary tumor retroviruses (MMTVs and Mtvs, respectively) (6) (7) (8) . Retroviruses are known to be potentially severe immunopathological agents. This fact has spurred the search for new superantigens of viral origin in humans. Although SAg-like properties have been suggested for HIV-1 (3, 9) this remains controversial (10) . To date, the only viral 1 Abbreviations used in this payer: LNC, lymph node cell; MMTV, mouse mammary tumor retrovirus; NC, nucleocapsid; SAg, superantigen; SEB, staphylococcal enterotoxin B.
SAg described in humans is the rabies virus nucleocapsid (NC) and its major component, the N protein (11) . NC consists of a viral strand of RNA covered with the three rabies viral core proteins, N, NS, and L. NC can bind to MHC class II molecules without processing and can stimulate in vitro Vfl8 human T lymphocytes (11) .
When SAgs are encountered during T cell development, they induce a decrease of reactive T cells by clonal deletion or by anergy (12, 13, 14) . Vfl-specific deletions occur in mouse pups due to the integration in the germ line of endogenous SAg encoded by Mtv provirus (15, 16) or due to infection by MMTVs present in the milk (17, 18) . Injection of the exogenous SAg staphylococcal enterotoxin B (SEB) into newborn animals also leads to clonal deletion (19) . However, before deletion, SAgs usually induce expansion of the target T cells bearing specific Vfl. This was the case for exogenous SAgs encoded by MMTV(SW) or for endogenous Mtv-8 and -9 SAgs (6, 20) . Expansion or deletion of entire Vfl subsets by a SAg is likely to exert a dramatic effect on pathogenesis of infection and host defense mechanisms and therefore on the outcome of infection. It has been shown that clonal dele-tion ofV•14 T cells obtained in transgenic mice by the overexpression of a V/314-specific MMTV, MMTV-C3H, prevents further MMTV-C3H infection (21) . Similarly, deletion of V~s induced by the presence of an endogenous Mtv in BALB/c has a drastic effect on resistance to experimental infection by the exogenous MMTV specific for the same target V~ (22) . Taken together, these results suggest that SAg-specific V~3s are crucial elements for the MMTV infection. As an explanation, it had been hypothesized that MMTV SAg amplifies MMTV infection because it stimulates the virus reservoirs, the B cells, with the help of the CD4 + T cells (6, 23, 24) .
Rabies virus infects almost all mammals including laboratory mice to which rabies virus strains have been adapted. T cells, especially CD4 + T cells, are an essential factor in host resistance to rabies virus (25) and also in the appearance of paralysis which is thought to be an inopportune consequences of the immune response (26, 27) . Since SAg stimulates T cells, it could be expected that a rabies SAg could activate the immune process and thus exacerbate the pathophysiological sequelae. An animal model is required to test this hypothesis.
In this work, we tested whether the NC SAg properties, already established in vitro with human T cells, existed also in mice. To do this, we analyzed whether NC can induce the expansion and the deletion of particular V~s in BALB/c mice. Then, we studied the role of NC-specific V~ T lymphocytes in the development of the clinical syndrome of immune-related paralysis.
Materials and Methods
Rabies NC. NC was purified from rabies virus-infected hamster (baby hamster kidney ceils clone SR [BSR]) ceil lysates through CsC1 gradients as previously described (28) . Cell cultures and virus seed lots were found to be mycoplasma free by specific hybridization, DNA staining and agarose isohtion techniques.
Mice. Three types of mice were used in these experiments: Injections. Baby mice, born from BALB/c mothers free of 5 MMTV(SW), were used for the neonatal deletion analysis. New-6 born mice were inoculated i.p. each every other day after birth with 7 50/zg of NC for a 2-wk period following a protocol previously 8.1,2 described (19) . Control animals were injected with RPMI 1640 medium. To reduce variability, new-born mice from multiple litters 8.1,2,3 were randomly assigned to tither sham-injected or NC-injected 9 litters. Mice were injected i.p. with 1 mg of hydrocortisone 2 d 10 before sacrifice to eliminate immature thymocytes (30) . Two mice 11 in each litter were sacrificed 4, 5, 6, 9, and 12wk afterbirth. These dates correspond respectively to 2--4, 6, and 10 wk after the last 14 NC injection. Spleen, thymus, and blood were taken from each 17 animal and double stained before being an,lyzed by cytofluorometry.
To analyze peripheral stimulations of T cells by NC, 8-to 11-wk-old female BALB/c, free of MMTV(SW), were injected with 3 to 80/zg of NC in each footpad according to an already described protocol (18) . Control mice were injected with CFA by the same route. Popliteal lymph node cells (LNCs) were removed 3, 5, 9, and 12 d, disrupted and double stained for flow cytometry analysis.
Staining and Flow Cytometric Anali~is. Splenocytes, thymocytes, and popliteal LNCs from both medium-and NC-injected animals were treated with buffered ammonium chloride to lyse erythrocytes and then washed twice in phosphate buffer saline containing Ca z § 2 + (PBS Ca 2 +/Mg z +). Circulating blood lymphocytes were obtained from blood of retro-orbital sinus, purified through Ficoll-Hypaque and washed twice in PBS Ca z+/Mg 2+. Lymphocytes were incubated with one of the V~-specilic biotinyhted mAbs ( Table 1) . PE-conjugated streptavidin was used as a second step in conjunction with FITC-conjugated hamster anti-CD3 + mAb 2Cll (31) 
Infection of Mice with Rabies Virus.
Mice were injected intramuscularly (i.m.) with 1 x 107 infectious particles of rabies virus Pasteur Virus strain (PV4) in both hind legs. Signs of weakness and paralysis and death were recorded every day up to 16 d after the virus injection. Weakness was determined by measuring the animal's ability to support its body weight with its hind legs. Paralysis was defined as a total loss of hind leg motility. In the rare cases of death, death by rabies was verified by checking for the presence of rabies virus in brains using immunofluorescence technique.
Transfer of VB T Lymphocytes. V~6 and VB8.1-3 T lymphocytes were extracted from spleens of 8-wk-old male BALB/c by panning using anti-V~6 and anti-V~8.1-3 mAbs (~hble 1). 14-wk-old male BALB/D2 were transfused by tail vein injection of 14 x 106 V~6 or V~8.1-3 T splenocytes. Control mice were not transfused. Each group contained four animals. 1 h after ceil transfer, mice were infected i.m. with rabies virus as described above. Mouse, SWR 1
Statistical Analysis. Differences between groups were analyzed using appropriate frequency analyses including student's t-test and chi-square calculations. 
Results

Neonatal Deletion in Newborn Mic~
Splenocytes and thymocytes from both medium and NC-injected animals
were double stained with one of the biotinyhted Vigspecific mAbs (Table  1 ) and then double stained and analyzed as in Fig. 1 thymus, (Fig. 2 B) and in the spleen. Percentages of V/36 CD4 + T cells were determined as above in two NC-injected and two control litters at 4, 6, 9, and 12 wk after birth. In spleens, as shown in Fig. 3 A, deletion of V/36 CD4 + T cells was detectable and maximal 5 wk after birth. Percentage of V/36 CD4 + was still reduced in 6-wk-old mice but returned to control level (i.e., ~9%) thereafter. The time course of VB6 deletion was also studied in circulating CD4 + T cells taken from the blood of four NC-injected offspring (Fig. 3 B) . Deletion was already achieved 4 wk after birth but disappeared after 6 wk. In thymus (Fig. 3 C) , the time course study indicates that the VB6 CD3 + deletion was maximal at 6 wk. Return to normal V/36 levels seemed to be less rapid in thymus than in the periphery.
Selective Expansion of Vff6 and Vff7 Expressing T Cells in Adult BALB/c Mice by NC Inoculation.
To analyze whether NC preferentially expands particular V/3s, we used the local injection technique which leads to a very strong T cell proliferation in the draining LNs. Adult BALB/c, 8-11-wk-old mice, free of exogenous MMTV(SW), were given footpad injections ofNC, CFA, or medium alone. 3 d after NC injection, the popliteal LNs of NC-injected mice increased in size about fivefold in comparison with LNs of naive, medium-injected mice. This increase was also observed after CFA injection but not after injection of medium alone. Popliteal LNs from both legs of NC-or CFA-injected mice, were removed and the percentages of CD4 + LNCs bearing V/32, 4, 6-8, 10, or 14 were estimated by cytofluorometry. Analysis of the size and granulometry indicated that the LN population obtained from control animals is homogeneous and is exclusively composed of resting lymphocytes. In contrast, activation with NC, in the test group, or CFA, in the control group, was characterized by the appearance of a blast population. Percentages of Vl3s obtained in CFA blasts were similar to those obtained in resting LNCs of naive mice (data not shown), indicating that the VB repertoire is not modulated by a non-specific inflammatory process. As shown in Fig. 4 , the number of CD4 + blasts expressing V/36 increased significantly from 9.6 + 1.7% in CFA-injected to 25.4 _+ 0.9% in NC-treated LNCs (t = 6.24, p <0.0001). The number of blasts expressing V/37 increased threefold from 4.6 _ 0.25% to 12.5 _+ 0.6% (t = 3.75, p = 0.0017). In two separate experiments, NC injection led to an increase of V/36 of up to 62% of the CD4 + blasts in four animals. In these cases, percent of V/37 T cells was not modified, suggesting the existence of a compensatory mechanism during the expansion of particular VBs (data not shown).
We demonstrated above that NC stimulates particular V/3 expressing CD4 + T cells. To test the effect of NC on CD8 + T cells, percentages of V/32, 6-8, and 14 were estimated among CD8 + LNCs. No significant changes of these V/3s could be observed between control and NC-injected LNCs (data not shown). This indicates that NC, in contrast to bacterial SAgs, does not stimulate peripheral mouse CD8 + T cells. 
Kinetics of NC Vff-specific Expansion and Dose-Respons,~ Ki-
Role of V~6 T Lymphocytes in Rabies Virus
Immunopathology. bies paralysis (22 or 0%) than normal BALB/c (75%), indicating that absence of NC-specific Vfl T cells protect mice against immune disorders. Age is an important co-factor in resistance to rabies morbidity in VB6-defident mice, since none of the 14-wk-old BALB/D2 developed signs of disease whereas 22% of 9-wk-old BALB/D2 became paralysed (Fig. 
5, middle).
To demonstrate the role of rabies SAg-target V~ T cells in rabies immunopathology, V/56 or V/38.1-3 T cells were transfused into BALB/D2 mice which normally lack these cells. Etfidency ofVfl6 reconstitution was checked 1 wk after transfer by analyzing circulating CD3 + blood cells (Fig. 6) . Range of Vfl6 CD3 + T cells counts were as follows: Vfl6 transfused mice: 2.5-5.6% (Fig. 6 E) nontransfused BALB/D2 controls: 0.6-0.7% (Fig. 6 A) and BALB/c, control 9-11% (Fig. 6 G) . In mice transfused with VB8 T cells, a few Vfl6 T cells, 1.7%, were detectable indicating that <1% (1.7-0.7%) ofVfl6 T cells were co-transferred with the Vfl8 T cells (Fig. 6 C) . Reconstitution with Vfl8.1-3 T cells did not modify the percentage of circulating Vfl8 T cells, since the percent of Vfl8 T cells in VflS-reconstituted mice was similar, (24-27% in Fig. 6/3 ) to the VB8 percentage in Vfl6-reconstituted mice (25-28% in Fig. 6 F) or in the nonreconstituted mice (28% in Fig. 6 B) . It is noteworthy that the anti-VB8 mAb, F23-1, which reacts with all three subsets of Vfl8 did not detect the wall-documented decrease of VflS-1 in BALB/D2 (28% of V88 are shown both in BALB/c and t~LB/D2). This could be due to a better affinity of mAb F23-I for the V~8.2 and V/38.3 than for the V~8.1 subset. Alternatively this may reflect compensatory mechanisms which keep constant the overall percentage of V158 T cells. Rabies immunopathology was compared in the V~6, the V~8-transfused BALB/D2-and in nontransfused BALB/D2 (Fig.   5, bottom) . All of the V~6-reconstituted BALB/D2 mice showed signs of severe paralysis as early as day 5, whereas all four of the nonreconsdtuted BALB/D2 mice remained free of paralysis. Among the V~8-reconstituted mice, only one, the one with 1.7% ofV~6 T cells showed limb weakness which progressed to paralysis by day 10 (1/4:25%). Taken together these results demonstrate that rabies immunopathology is dependent on the presence of V~6 T cells.
Although the immunopathological sign of hind limb paralysis is common in these mice, death is rare. In contrast to what has been observed in BALB/D2 mice, where the PV4 rabies virus is rarely fatal (3 out of 35 infected mice), it is noteworthy that all the VB6 reconstituted BALB/D2 mice died of rabies by day 18.
Dhcuss/on
Recognition of a SAg by an host is a two-step reaction: first, SAg triggers the expansion of certain TCR Vfl subsets and later on, the expanded T cells enter into an unresponsive state and then die. An encounter at birth with SAg leads to a loss of most T cells expressing the reactive TCR Vfls during maturation in thymus (15) . Clonal deletion of some entire VB subsets is regarded as a perquisite for a SAg. By showing that NC deletes T cells bearing particular VBs in mice, we demonstrated that NC is a superantigen and we strengthened the previous results obtained in vitro with human lymphocytes where NC expands VB8 T cells, binds to surface class II molecules, probably by the ct chain, and does not require processing (11) . Taken together, these data lead to the conclusion that NC behaves as a SAg in both humans and mice and emphasize the point that viruses other than mouse retrovirus can also encode SAgs.
Demonstration that NC is a SAg for the mouse provides an experimental means to further investigate the role of rabies SAg in vaccination and in host infection. In this paper, we focused our attention on the role of rabies SAg in rabies infection and more precisely in rabies immunopathology. After rabies virus enters both sensory and motor nerve ending, it replicates in the neuronal cell bodies of the ganglia. Then, the virus invades the central nervous system. Rabies can result in two forms of disease: the encephalitic disease and the paralytic (32) . In contrast to the encephalitic form of rabies, the paralytic form of rabies is characterized by a rapid dearance of rabies virus and by an almost complete absence of lethal outcome. Limb paralysis results from a peripheral immunopathological process which causes mononudear cells infiltration and destroys the sciatic nerve (32, 26) . Paralysis is not observed in immunosuppressed mice or in nude mice but is seen after T cell reconstitution, indicating that T cells play a crucial role in the induction of rabies paralysis (26, 32, 33) . The mechanism of this process remains unknown. At least, it is not mediated by cytotoxic CD8 + T cells, since removal of CD8 + T cells does not protect against paralysis (27) . We postulate that a component of the rabies virus which can stimulate T calls strongly, such as the NC SAg, may play a role in this process. Our data strongly support this hypothesis; we found that: (a) rabies immunopathology was decreased in BALB/c missing the NC-specific Vfls; (b) transfer of NC main targets V/36 T cells but not of VB8.1-3 T cells into deficient mice reactivated rabies virus immune-related pathology; and that (c) susceptibility to paralysis increases with the number of Vfl6 T cells. The finding that some of 9-wk-old BALB/D2 with 1.2% of Vfl6, were paralyzed whereas the 14-wk-old BALB/D2, with 0.6% of VB6) remain free of symptoms suggests that the 9-wk-old BALB/D2 show an immunopathological response to rabies because of the presence of a few remaining Vfl6 T cells (1.2%). In contrast the 14-wk-old BALB/D were protected because traces of Vfl6 (0.6%) were not sufficient to induce paralysis. Age dependence of the number of Vfl6 among BALB/D2 is consistent with the observation that complete deletion of Mtv targets V~s is progressively acquired and only occurs after 10 wk (34) . Similarly, VflS-transferred BALB/D2 mice expressing 1.7% of V/36 T cells were only partially paralyzed whereas all the mice expressing more than 2% of V~6 T cells were paralyzed. Thus, the threshold of V/36 T cells required for significant paralysis seems to be approximatively fixed around 2%. Altogether, these results strongly support the hypothesis that T cells expressing rabies SAg-spedfic V~6 T cells, are involved in rabies virus immunopathology.
We cannot rule out that other Vfl play a role in immunopathology since the mice which are less susceptible to rabies immunopathology also miss the Vfl7 T cells in addition to the Vfl6 T cells. These ceils were also expanded in the periphery after NC injection (Fig. 4) , however their expansion was less important than the Vfl6 T cells expansion. Moreover, the V~7 T cells were not significantly deleted after neonatal expansion (Fig. 2) suggesting that NC may have a better affinity for V/36 TCR than for V~7 TCR. The discrepancy between expansion and deletion of Vfl7 T calls by NC can be linked to the observation that expansion induced by superantigens, such as TSST-1, is not always followed by anergy and thus by deletion (35) .
Previous observations that CD8 + T cells are not involved in rabies immunopathology and the present finding that CD8 + T cells are not specific targets of rabies SAg strongly support the hypothesis that SAg-related immunopathology is deserved only by the V~6 CD4 + T cells.
Enhancement of rabies immunopathology by NC may be obtained because NC triggers an efficient Vfl6 CD4 + T cell-mediated immune response which destroys the infected neurons in the periphery. Neurons normally do not express MHC class II molecules. INF-3, is able to stimulate MHC class II production. It cannot be excluded that SAgs which are known to make T cells to release large amounts of cytokines (36, 37) , could trigger MHC class II expression on neuronal cells which became suitable targets for cytotoxic T cells. Alternatively, destruction of neurons could be obtained indirectly by killer microglia cells with the help of antibodies, via the mechanism of anta~xxly-dependent cell cytotaxidty, the ADCC. Evidence has been obtained in mice that NC stimulates the production of neutralizing antibodies directed against the rabies virus envelope protein (38) suggesting that rabies SAg can induce cognate T-B interactions. In this hypothesis, rabies SAg could enhance the antibody response and induce an antibody-rehted immunopathology. It is not yet dear whether this immune response is sufficient to rid the nervous system of rabies virus. In the case of rabies, the balance between the immune response and the virus infection seems to play a key role in the issue of the disease. Several reports have noted that infected individuals died of rabies despite a strong immune response suggesting that, most of the time, the immune response is launched too late to be efficient. Delay in the establishment of the immune response could explain the discrepancy observed between the issue of the transfer experiment, where BALB/D2 + VB6 died, and the experiment where NC induces protection (38) . In our reconstitution experiment, VB6-transfused mice died despite a strong paralysis, whereas after the injection of NC a few hours or days before virus, paralyzed mice were protected (38) .
The finding that NC can exacerbate the rabies immunopathology in mice raises the questions about a possible role for NC in producing the high incidence of neurological complications that follows vaccination in humans using rabies vaccines prepared in animal brain. Rabies infection can be prevented in humans exposed to rabid animals by prompt administration of rabies vaccine. In several countries, such as Brazil or India, economic reasons necessitate the use of rabies vaccines prepared from inactivated rabies-infected animal brains despite the neurological complications. Multiple injections of this vaccine over a 2-wk period are required to trigger an efficient immune response. We found that, in contrast to rabies vaccine prepared in tissue culture, the animal brain vaccine contains large amounts of NC (Montano-Hirose, J. A., and M. Lafon, manuscript in preparation).
More experiments are needed to establish whether neuropathological vaccine disorders may be linked to the presence of NC in brain rabies vaccines and to understand the mechanisms that can allow protection to rabies infection. The answers to these questions, in addition giving new insights in the role of SAg in infection, will have considerable consequence for vaccine design.
